Cargando…

Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice

There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artific...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbavor, Felix, Liang, Hualou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856143/
https://www.ncbi.nlm.nih.gov/pubmed/36672010
http://dx.doi.org/10.3390/brainsci13010028
_version_ 1784873551269986304
author Agbavor, Felix
Liang, Hualou
author_facet Agbavor, Felix
Liang, Hualou
author_sort Agbavor, Felix
collection PubMed
description There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artificial intelligence (AI)-powered end-to-end system to detect AD and predict its severity directly from voice recordings. At the core of our system is the pre-trained data2vec model, the first high-performance self-supervised algorithm that works for speech, vision, and text. Our model was internally evaluated on the ADReSSo (Alzheimer’s Dementia Recognition through Spontaneous Speech only) dataset containing voice recordings of subjects describing the Cookie Theft picture, and externally validated on a test dataset from DementiaBank. The AI model can detect AD with average area under the curve (AUC) of 0.846 and 0.835 on held-out and external test set, respectively. The model was well-calibrated (Hosmer-Lemeshow goodness-of-fit p-value = 0.9616). Moreover, the model can reliably predict the subject’s cognitive testing score solely based on raw voice recordings. Our study demonstrates the feasibility of using the AI-powered end-to-end model for early AD diagnosis and severity prediction directly based on voice, showing its potential for screening Alzheimer’s disease in a community setting.
format Online
Article
Text
id pubmed-9856143
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98561432023-01-21 Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice Agbavor, Felix Liang, Hualou Brain Sci Article There is currently no simple, widely available screening method for Alzheimer’s disease (AD), partly because the diagnosis of AD is complex and typically involves expensive and sometimes invasive tests not commonly available outside highly specialized clinical settings. Here, we developed an artificial intelligence (AI)-powered end-to-end system to detect AD and predict its severity directly from voice recordings. At the core of our system is the pre-trained data2vec model, the first high-performance self-supervised algorithm that works for speech, vision, and text. Our model was internally evaluated on the ADReSSo (Alzheimer’s Dementia Recognition through Spontaneous Speech only) dataset containing voice recordings of subjects describing the Cookie Theft picture, and externally validated on a test dataset from DementiaBank. The AI model can detect AD with average area under the curve (AUC) of 0.846 and 0.835 on held-out and external test set, respectively. The model was well-calibrated (Hosmer-Lemeshow goodness-of-fit p-value = 0.9616). Moreover, the model can reliably predict the subject’s cognitive testing score solely based on raw voice recordings. Our study demonstrates the feasibility of using the AI-powered end-to-end model for early AD diagnosis and severity prediction directly based on voice, showing its potential for screening Alzheimer’s disease in a community setting. MDPI 2022-12-23 /pmc/articles/PMC9856143/ /pubmed/36672010 http://dx.doi.org/10.3390/brainsci13010028 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Agbavor, Felix
Liang, Hualou
Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title_full Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title_fullStr Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title_full_unstemmed Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title_short Artificial Intelligence-Enabled End-To-End Detection and Assessment of Alzheimer’s Disease Using Voice
title_sort artificial intelligence-enabled end-to-end detection and assessment of alzheimer’s disease using voice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856143/
https://www.ncbi.nlm.nih.gov/pubmed/36672010
http://dx.doi.org/10.3390/brainsci13010028
work_keys_str_mv AT agbavorfelix artificialintelligenceenabledendtoenddetectionandassessmentofalzheimersdiseaseusingvoice
AT lianghualou artificialintelligenceenabledendtoenddetectionandassessmentofalzheimersdiseaseusingvoice